These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 18988264)
1. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography. Zhang M; Lute S; Norling L; Hong C; Safta A; O'Connor D; Bernstein LJ; Wang H; Blank G; Brorson K; Chen Q Biotechnol Bioeng; 2009 Apr; 102(5):1438-47. PubMed ID: 18988264 [TBL] [Abstract][Full Text] [Related]
2. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification. Shi L; Chen Q; Norling LA; Lau AS; Krejci S; Xu Y Biotechnol Bioeng; 2004 Sep; 87(7):884-96. PubMed ID: 15334415 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture. Brorson K; Xu Y; Swann PG; Hamilton E; Mustafa M; de Wit C; Norling LA; Stein KE Biologicals; 2002 Mar; 30(1):15-26. PubMed ID: 11846426 [TBL] [Abstract][Full Text] [Related]
4. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture. de Wit C; Fautz C; Xu Y Biologicals; 2000 Sep; 28(3):137-48. PubMed ID: 10964440 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156 [TBL] [Abstract][Full Text] [Related]
6. Impact of cell culture process changes on endogenous retrovirus expression. Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857 [TBL] [Abstract][Full Text] [Related]
7. Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing. Brorson K; Swann PG; Lizzio E; Maudru T; Peden K; Stein KE Biotechnol Prog; 2001; 17(1):188-96. PubMed ID: 11170498 [TBL] [Abstract][Full Text] [Related]
8. Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay. Chang A; Dusing S Dev Biol (Basel); 2006; 123():91-7; discussion 119-32. PubMed ID: 16566438 [TBL] [Abstract][Full Text] [Related]
9. Removal of endogenous retrovirus-like particles from CHO-cell derived products using Q sepharose fast flow chromatography. Strauss DM; Lute S; Brorson K; Blank GS; Chen Q; Yang B Biotechnol Prog; 2009; 25(4):1194-7. PubMed ID: 19452543 [TBL] [Abstract][Full Text] [Related]
10. Quality by design approach for viral clearance by protein a chromatography. Zhang M; Miesegaes GR; Lee M; Coleman D; Yang B; Trexler-Schmidt M; Norling L; Lester P; Brorson KA; Chen Q Biotechnol Bioeng; 2014 Jan; 111(1):95-103. PubMed ID: 23860745 [TBL] [Abstract][Full Text] [Related]
11. Robustness of virus removal by protein A chromatography is independent of media lifetime. Lute S; Norling L; Hanson M; Emery R; Stinson D; Padua K; Blank G; Chen Q; Brorson K J Chromatogr A; 2008 Sep; 1205(1-2):17-25. PubMed ID: 18722622 [TBL] [Abstract][Full Text] [Related]
12. Multiplex RT Q-PCR assay for simultaneous quantification of three viruses used for validation of virus clearance by biopharmaceutical production. Lute S; Wang H; Sanchez D; Barletta J; Chen Q; Brorson K Biologicals; 2009 Oct; 37(5):331-7. PubMed ID: 19683941 [TBL] [Abstract][Full Text] [Related]
13. Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells. Anderson KP; Lie YS; Low MA; Williams SR; Wurm FM; Dinowitz M Dev Biol Stand; 1991; 75():123-32. PubMed ID: 1665459 [TBL] [Abstract][Full Text] [Related]
14. Strategies for developing design spaces for viral clearance by anion exchange chromatography during monoclonal antibody production. Strauss DM; Cano T; Cai N; Delucchi H; Plancarte M; Coleman D; Blank GS; Chen Q; Yang B Biotechnol Prog; 2010; 26(3):750-5. PubMed ID: 20306523 [TBL] [Abstract][Full Text] [Related]
15. Experiences of virus, retrovirus and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Adamson SR Dev Biol Stand; 1998; 93():89-96. PubMed ID: 9737383 [TBL] [Abstract][Full Text] [Related]
16. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity. Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176 [TBL] [Abstract][Full Text] [Related]
17. Application of multivirus spike approach for viral clearance evaluation. Valera CR; Chen JW; Xu Y Biotechnol Bioeng; 2003 Dec; 84(6):714-22. PubMed ID: 14595784 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII. Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114 [TBL] [Abstract][Full Text] [Related]
19. Quantitative competitive reverse transcription-PCR as a method to evaluate retrovirus removal during chromatography procedures. Lau AS; Lie YS; Norling LA; Sernatinger J; Dinowitz M; Petropoulos CJ; Xu Y J Biotechnol; 1999 Oct; 75(2-3):105-15. PubMed ID: 10553652 [TBL] [Abstract][Full Text] [Related]
20. Real time quantitative PCR as a method to evaluate simian virus 40 removal during pharmaceutical protein purification. Shi L; Norling LA; Lau AS; Krejci S; Laney AJ; Xu Y Biologicals; 1999 Sep; 27(3):253-62. PubMed ID: 10652180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]